NTORS and the 3 for 1 bargain

Similar documents
The story of drug treatment

drug treatment in england: the road to recovery

Specialist drug and alcohol services for young people a cost benefit analysis

THE STORY OF DRUG TREATMENT

Why invest? How drug treatment and recovery services work for individuals, communities and society

Effectiveness of Treatment The Evidence

Universities of Leeds, Sheffield and York

Getting help for a drug problem A guide to treatment

FALLING DRUG USE: THE IMPACT OF TREATMENT

THE DRUG DETOX UNIT AT MOUNTJOY PRISON A REVIEW

A LONG-TERM STUDY OF THE OUTCOMES OF DRUG USERS LEAVING TREATMENT SEPTEMBER 2010

Drug Treatment System in the UK. Dr. Lisa Luger, LLC Consultancy CIC, London

Treat addiction, cut crime. How treatment and recovery services reduce drug-related offending

The National Community Detoxification Pilot

Specialist drug and alcohol services for young people a cost benefit analysis

TREATMENT OF DRUG USERS (SCOTLAND) BILL

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SPECIAL HEALTH AUTHORITY TENTH WAVE WORK PROGRAMME DRUG MISUSE. Psychosocial interventions in drug misuse

To detox or not to detox: whose choice is it anyway? Dr Ed Day Senior Lecturer in Addiction Psychiatry University of Birmingham

Specialist Alcohol & Drug Services in Lanarkshire

Joint Committee on Health and Children

Treatment Approaches for Drug Addiction

Current Model of Drug Care. Components of a Full Drug Care Service

NTORS After Five Years

Treatment Approaches for Drug Addiction

POWDER COCAINE: HOW THE TREATMENT SYSTEM IS RESPONDING TO A GROWING PROBLEM

BUILDING RECOVERY IN COMMUNITIES

OPTUM By United Behavioral Health OPTUM GUIDELINE EVIDENCE BASE: Level of Care Guidelines

London: boom or bust

Safer Stronger Communities Select Committee

Wairarapa Wellness. A brief overview of mental health and addiction services in Wairarapa.

Abstinence and drug abuse treatment: Results from the Drug Outcome Research in Scotland study

THE ROLE OF RESIDENTIAL REHAB IN AN INTEGRATED TREATMENT SYSTEM

The Government's Drug Strategy

A copy can be downloaded for personal non-commercial research or study, without prior permission or charge

INTRODUCTION. a. Value of merchandise stolen. b. Costs of medical care for crime victims. c. Productivity losses. d. Cost for police protection.

Topic Area - Dual Diagnosis

No.1 Why reducing drug-related crime is important, and why the new government needs to act

Costing report. Drug misuse: psychosocial interventions and opioid detoxification. Implementing NICE guidance. July 2007

Adult drug treatment plan 2009/10. Part 1: Strategic summary, needs assessment and key priorities

debatepolicy rethink justice Searching for a fix Drug misuse, crime and the criminal justice system

The Drug Treatment Outcomes Research Study (DTORS): Final outcomes report 3rd Edition

Consultation on Future Drug and Alcohol Services in Shropshire

Reshaping Drug and Alcohol Treatment in Westminster. Public Consultation

Contact for further information: Chris Lee, , Adult Services, Health and Wellbeing Directorate,

THE DATA FOR ADULT DRUG TREATMENT LINCOLNSHIRE LINCOLNSHIRE E08B 32

Reducing Drug Use, Reducing Reoffending Are programmes for problem drug-using offenders in the UK supported by the evidence?

Prescription Painkiller/Heroin Addiction and Treatment: Public and Patient Perceptions

Crime Location Crime Type Month Year Betting Shop Criminal Damage April 2010 Betting Shop Theft April 2010 Betting Shop Assault April 2010

Alcohol and drugs prevention, treatment and recovery: why invest?

Cost and Benefits of Therapeutic Communities

Southlake Psychiatry. Suboxone Contract

What are the outcomes for assessing drug treatment? A review of long-term observational studies on the treatment of opioid dependence

Summary Document: Rapid Appraisal of the Liverpool Drugs Intervention Programme January 2005

Alcohol and Re-offending Who Cares?

Outcomes for Opiate Users at FRN Facilities. FRN Research Report September 2014

DMRI Drug Misuse Research Initiative

Consultation Paper on Commissioning Adults and Young People s Drug and Alcohol Services in Somerset

DEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd

Adults who misuse drugs and alcohol

National Drug Treatment Monitoring System (NDTMS) NDTMS DATA SET H

Payment by Results for Drug Recovery Pilot

People affected by drug and alcohol misuse

Understanding the Costs and Savings to Public Services of Different Treatment Pathways for Clients Dependent on Opiates

DrugFacts: Treatment Approaches for Drug Addiction

St. Mark s House Residential Detoxification. Client Guide

Health Select Committee Inquiry: the Government s Alcohol Strategy

life Instead of 12 steps, our clients just take one. Create a worth living. Addiction treatment as unique as the individual in need.

Treatment Approaches for Drug Addiction

Details of need and our response can be found in the DAAT Treatment Plan which is available at

TITLE: REVIEW OF DRUG USE IN HARLOW (PART 2 OF 2) LYNN SEWARD, HEAD OF COMMUNITY WELLBEING (01279) TEAM MANAGER (01279)

Report of Lorraine O Donnell, Assistant Chief Executive

Phoenix Futures Prison Treatment programmes

HOSC Report Integrated community drugs and alcohol service retendering options beyond April 2016

Submission to Department of Public Expenditure and Reform on comprehensive review of public expenditure

Criminal Justice Integrated Drug Teams and treatment interventions. Clinical guidance to maximise access to drug treatment

Dual Diagnosis. Dual Diagnosis Good Practice Guidance, Dept of Health (2002);

WHAT WE KNOW. Collective Action Issue Brief #2 Updated June 2014 PRESCRIPTION PAIN MEDICATION MISUSE

Adult drug treatment plan 2007/08 Part 1 Section A: Strategic summary Section B: National targets Section C: Partnership performance expectations

THE INDEPENDENCE INITIATIVE: AN EVALUATION OF EFFECTIVENESS EXECUTIVE SUMMARY Jim McVeigh & Paul Duffy. Foreword

August A. Introduction

Audit of the First Twelve months of Cuan Dara Detoxification Unit July 95 to July 96

SOMERSET DUAL DIAGNOSIS PROTOCOL OCTOBER 2011

Research Note RN 00/91 1 November 2000 DRUG COURTS

The Corrosive Effects of Alcohol and Drug Misuse on NH s Workforce and Economy SUMMARY REPORT. Prepared by:

Prescription Painkiller/Heroin Addiction and Treatment: The Patient Perception. Highlights

Clinical Priorities for Alcohol and Drugs in Public Health

Developing the Guernsey treatment system for substance misusers: Phases One and Two. Helen Baldwin Linda Prickett Adam Marr Jim McVeigh

The Swanswell Recovery Model. Evaluation Report

The Criminal Justice Intervention Programme & Primary Care.

Trends in deaths related to drug misuse in England and Wales,

DMRI Drug Misuse Research Initiative

Florida s Mandatory Minimum Drug Laws: Ineffective, Expensive, and Counterproductive

Theft Offences Definitive Guideline DEFINITIVE GUIDELINE

research Residential detoxification and rehabilitation services for drug users: A review Effective Interventions Unit Tackling Drugs in Scotland

GUIDANCE Implementing Section 176 of the Anti-social Behaviour, Crime and Policing Act 2014: Lowvalue

The Start of a Criminal Career: Does the Type of Debut Offence Predict Future Offending? Research Report 77. Natalie Owen & Christine Cooper

Substance Misuse Treatment Investment. Cost Benefit Analysis

Who benefits from the Rehabilitation of Offenders Act and how?

Pioneering Detox and Rehab Choice

Assessing the impact of drug law enforcement activities in one London borough

Transcription:

NTORS and the 3 for 1 bargain The best known and most influential finding in British addiction treatment 3 savings to society for every spent on treatment. From the mid-'90s NTORS study, this finding underpinned the expansion of treatment as a means of cutting the burden of crime. Both sides of the equation rested on assumptions seemingly so convenient for everyone concerned that their fragility was overlooked. Then as now methadone was under attack. The NTORS findings saved it from a hostile health minister but left it hostage to a precarious and limited justification. Chickens have come home to roost.

The context Abstentionist health minister Brian Mawhinney saw methadone as perpetuating addiction... we will be looking to get people off drugs sound familiar? Specialist inpatient units and residential rehabs too were under threat from cost constraints and public service reforms. Mawhinney condemned the drug industry who resist any threat to their present autonomy. Ironically, the review he set up commissioned its key research project from the heart of that industry, the National Addiction Centre, whose allied health services provided the treatments under attack. Their findings would be crucial to the survival and development of the UK s drug treatment provision.

The study From March to July 1995, 1075 drug users starting treatment were interviewed for the research and then followed up to see whether they improved. They were attending typical English inpatient detoxification, residential rehabilitation or outpatient methadone programmes. Most were using heroin. Headline finding: for every extra 1 spent on drug misuse treatment, more than 3 is saved on costs of crime Public Health Minister Tessa Jowell.

What was the 1? Like drugs policy coordinator Jack Cunningham, most people forgot the word extra ; 3 for 1 became the mantra. They assumed the was the full cost of the treatments studied in NTORS; understandable and the way other studies had done similar calculations. It wasn t it was just over half. At a stroke the cost-savings ratio had been nearly doubled.

1 extra on treatment nets 3 savings Extra 1.6m in NTORS year 5.2 million How the NTORS team calculated it Treatment costs Cost-savings from crime reductions

Extra 1.6m in NTORS year Remaining 1.4m in NTORS year 5.2 million How other studies would have calculated it Treatment costs Cost-savings from crime reductions

Extra 1.6m in NTORS year Remaining 1.4m in NTORS year 1.4m in year before NTORS 5.2 million How it might have been calculated Treatment costs Cost-savings from crime reductions

What was the 3? The costs imposed on the rest of us due to crimes committed by the NTORS patients in the year before minus the year after they after they started treatment. Questionable assumptions inflated this to perhaps more than twice the value it would have been had different assumptions been made. Here s how it happened.

Rate of offending Year before Treatment entry Year after

Average rate Rate of offending Total offences before Total offences after Year before Treatment entry Year after

Average rate Rate of offending Year before Treatment entry Year after

Average rate Rate of offending Total offences before Total offences after Year before Treatment entry Year after

Number of clients convicted in each year Treatment entry

Extra 1.6m in NTORS year Remaining 1.4m in NTORS year 1.4m in year before NTORS 5.2 million How it might have been calculated Treatment costs Cost-savings from crime reductions

NTORS We included all costs to households and retailers... stolen property largely reflects a transfer of well-being from the victim to the criminal. However, unlike other transfers (eg, welfare payments, gifts) they involve a violation of victim property rights. For this reason they were included in reported cost estimates. Simoens Losses from criminal activity in fact constitute a transfer payment within society rather than impose an additional cost on society and, hence, should not be counted from a societal perspective." Home Office Burglary, theft or robbery involves an illegal transfer of property that is unwanted by one party, the victim, and the transfer of the property out of the legal economy. This study treats transfers out of the legal economy and into the illegal economy as costs of crime. Institute for Criminal Policy Research Some members of some communities that host drug markets clearly benefit from having a local illicit economy. The market for stolen goods that they stimulate can help people living in extreme poverty.

For NTORS and its 3 for 1 ratio, what would the consequence have been of treating stolen property and money as transfer payments? I ve made an amateur stab at estimating it by combining... 1. NTORS data on the costs of shoplifting, burglary robbery, drug offences, and fraud committed by the NTORS patients in the two years before and after treatment with... 2. Home Office estimates of the costs of those crime which (not for all) break these costs down in to their components including stolen property or defrauded money. The result...

The cost savings estimate in the NTORS study was cut by nearly half

3m cost of treatment in first year NTORS study 4.4m including previous year Extra 1.6m in NTORS year Remaining 1.4m in NTORS year 1.4m in year before NTORS Does treatment really save more in crime than it costs? 2.9 million Treatment costs Cost-savings from crime reductions excluding transfers

CALDATA Sampled 3000 people discharged from drug or alcohol treatment centres (or remaining on methadone). Estimated the costs saved by society most of which related to crime. Made two savings estimates: 1. to taxpaying citizens 2. to total society Main difference: taxpaying citizens benefit when there is less theft and other crime [and welfare payments]. However, these transfers... are considered economically neutral to the total society, since one person s loss equals another s gain.

The result On model one savings to taxpaying citizens including transfer payments the savings were $1493 million over the period of treatment and in the year after. On model two savings to total society which excluded transfer payments the savings were $454 million.

Does this mean the treatments studied in NTORS did not create benefits for society? NO! It just means that given what it measured, it s questionable whether NTORS demonstrated such benefits in economic terms. Benefits there certainly were in terms of saved and improved lives. These were not included in NTORS economic estimates, leaving crime as the main component.

Postscript: inpatient detoxification NTORS generally lumped together inpatient detoxification and residential rehabilitation programmes as residential services. It didn t seem to make sense. Typically inpatients want to become drugfree, rehabilitation residents to remain so. Inpatient stays are usually much shorter. Chalk was being merged with cheese. 1 What was the effect? 122 of the sample were inpatients, 286 rehab residents, so the merged outcomes largely reflected the work of the rehabilitation services. An opportunity to assess the work of half 2 England s inpatient services was lost. But not entirely...

Doors close after six months The first published outcome report (six month follow-up) did separate rehabilitation and detoxification units. 1 How did they do? Almost as well with respect to opioid use and associated injecting frequency, much worse in nearly every other respect. 2 Residential rehabilitation units had a full flush of 8 substance use and infection risk measures on which residents improved to a highly statistically significant degree; inpatient units, 3 out of 8. By the time the one-year outcomes were reported, the doors had closed and the (poor?) performance of the inpatient centres was submerged among the successes of the rehabilitation units. But not entirely...

Neglected cost-effectiveness analysis exposes inpatient services In 2003 one NTORS cost-effectiveness analysis did separate rehabilitation and detoxification units. 1 It was based on crime outcomes for heroin users measured one year after starting treatment. Here s the reference: Healey A., Knapp M., Marsden J., Gossop M., Stewart D. Criminal outcomes and costs of treatment services for injecting and non-injecting heroin users: evidence from a national prospective cohort survey. Journal of Health Services Research and Policy: 2003, 8, p. 134 141. It is the only paper to show how these services performed uncontaminated by results from the other set of services. Given this, what s remarkable is where it was not mentioned.

It was not mentioned in a later NTORS economic analysis, even though two of the authors were also responsible for the earlier paper. 1 It was missed too from NTA commissioning guidance for residential and inpatient services published three years later in 2006. 2 Not surprising, because it was also missing the year before from the NTA s research briefing on inpatient opiate detoxification, even though this included cost effectiveness data. 3 Missed too when in the same year a government-funded network of UK doctors specialising in addiction supportively reported on the evidence for inpatient services. 4 But it wasn t invisible. It has been cited by at least 12 other papers 5 including a review conducted for NICE but that was on substitute prescribing. 6

How did the detox services perform? How did the detoxification services perform without their rehab camouflage? The analysis separated the injectors (around 6 in 10 of the sample) from the non-injectors. There was no 'no treatment' control group, so instead an estimate was made of what the crime reductions (from before to after treatment) would have been without treatment, and this was compared with an estimate of what they actually were after an average stay. Non-injectors did well whichever type of service (inpatient, rehab or methadone) they were treated in. Injectors were more treatment resistant. In fact, if you excluded a handful of extraordinarily prolific offenders

Detox counterproductive for injectors? for heroin injectors, an average stay in a detoxification unit was estimated to have led to a higher crime rate than if the patients had never been treated. In other words, for typical injectors these services were negatively cost effective. Every 80 spent putting patients through these services was associated with one extra crime committed. This was just an estimate based on the association between longer stays and the later crime rate extrapolated back to a 0 day stay, ie, no treatment. But of course there was no real 'no treatment' control group. And the results were different for non-injectors and if the handful of extraordinarily prolific offenders were included in the analysis. But had these results been widely known, could the recent investment in these services have been justified?

More in: Ashton M. NTORS: the most crucial test yet for addiction treatment in Britain. Drug and Alcohol Findings: 1999, 2. http://findings.org.uk/docs/ashton_m_12.pdf